Drug intelligence / Profile preview

clomiphene citrate + estradiol

Development stage
Preclinical
Lead developer
Procter & Gamble
Modality
Small Molecules
Administration
Oral, Transdermal
01

Overview

Clomiphene citrate + estradiol is a combination therapy used primarily in the management of infertility, particularly for women with diminished ovarian reserve or poor response to standard ovulation induction protocols. Clomiphene citrate is a selective estrogen receptor modulator (SERM) that acts as an ovulatory stimulant by binding to estrogen receptors in the hypothalamus and pituitary, leading to increased release of gonadotropins (FSH and LH), which stimulate follicular development and ovulation[5][6]. Estradiol is a natural estrogen hormone that can be added to counteract the anti-estrogenic effects of clomiphene on endometrial tissue, potentially improving endometrial receptivity for embryo implantation[1][2]. The combination has been studied as part of minimal ovarian stimulation protocols in assisted reproductive technology (ART), such as IVF, especially for patients with diminished ovarian reserve. The addition of estradiol may reduce cycle cancellation rates and increase oocyte yield compared to either agent alone[1].

Other names
clomiphene + estradiolCC + E2
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on clomiphene citrate + estradiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clomiphene citrate + estradiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call